Neurofibromatosis type 1 (NF1) is the most common genetic disorder with a predisposition to malignancy and affects one in 3500 persons worldwide. 
ABSTRACT:
Neurofibromatosis type 1 (NF1) is the most common genetic disorder with a predisposition to malignancy and affects one in 3500 persons worldwide.
1,2 NF1 is caused by a mutation in the NF1 tumor suppressor gene that encodes the protein neurofibromin. 3, 4 Patients with NF1 suffer from cutaneous, diffuse, and plexiform neurofibromas, tumors comprised primarily of Schwann cells, blood vessels, fibroblasts, and mast cells. Studies from human and murine models that closely recapitulate human plexiform neurofibroma formation indicate that tumorigenesis necessitates NF1 loss of heterozygosity (LOH) in the Schwann cell. Additionally, our most recent studies with bone marrow transplantation and pharmacologic experiments implicate haploinsufficiency of Nf1 (Nf1 +/-) and c-kit signaling in the hematopoietic system as required and sufficient for tumor progression. 5 Here, we review recent studies implicating the hematopoietic system in plexiform neurofibroma genesis, delineate the physiology of SCF-dependent hematopoietic cells and their contribution to the neurofibroma microenvironment, and highlight the application of this research toward the first successful, targeted medical treatment of a patient suffering from a nonresectable and debilitating neurofibroma. Finally, we emphasize the importance of the tumor microenvironment hypothesis, asserting that tumorigenic cells in the neurofibroma do not arise and grow in isolation.
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INTRODUCTION:
Although several reports characterized NF1 or NF1-like syndromes as early as the 18 th century, [6] [7] [8] Friedrich von Recklinghausen did not publish his seminal, detailed case reports until 1882. 9 Von Recklinghausen observed that neurofibromas contain elements of both neuronal and fibroblastic tissue. In 1911, H. Greggio reported his observation that mast cells infiltrate the neurofibroma. 10, 11 Vincent Riccardi later postulated a pivotal role for mast cells and melanocytes in NF1 pruritis, pigmentation defects, and, potentially, neurofibroma formation. 12 Today, NF1 is recognized as a common and fully penetrant genetic disease demonstrating variable expressivity. 11 The disease is transmitted in an autosomal dominant fashion as a mutation in NF1, a tumor suppressor gene encoding the protein Neurofibromin. Neurofibromin functions as a p21 ras (Ras) guanosine tri-phosphotase (GTP) activating protein (GAP), accelerating the hydrolysis of Ras-GTP thousands of fold and functioning at least in part to negatively regulate multiple Ras-dependent cellular signaling pathways. 11, [13] [14] [15] [16] [17] Mutations of NF1 predispose patients to variable neuronal, hematopoietic, and skeletal pathologies, including myeloid leukemia, kyphoscoliosis, long bone pseudoarthrosis, and cutaneous, subcutaneous, and diffuse plexiform neurofibromas. 11, 18 Neurofibromas are pathognomonic for the disease. Cutaneous neurofibromas arise from small peripheral nerves during adolescence or adulthood and are observed in over 95% of NF1 patients ( Figure 1 , left panel). 19 Plexiform neurofibromas, by contrast, appear in about 15-40% of NF1 patients and arise during early development from cranial nerves and proximal large peripheral nerve sheaths 
Generation of a conditional Nf1 knockout
The early embryonic deaths of Nf1 -/-mice generated using traditional 
potentially regulate the G1-to S-phase transition. 68, [72] [73] [74] Additional data indicate that SCF-dependent activation of Rac2, the highly-expressed hematopoietic Rho GTPase isoform, phosphorylates Akt, which modulates the Bcl-2 family of proteins to prevent apoptosis, increasing mast cell survival. 71 Because neurofibromin negatively regulates
Ras-GTP and its multiple downstream targets, these data mechanistically explain aberrant function in the Nf1 +/-mast cell, providing potential therapeutic targets along the Raf-MEK-ERK and PI-3K-Rac-Pak-p38 pathways. (Figure 3 ).
Fibroblasts
In +/-mast cell conditioned media compared to WT conditioned media induced higher fibroblast bioactivity as measured by proliferation, migration, and collagen production.
The study confirmed this heightened fibroblast bioactivity to be TGF-ß dependent by neutralizing Nf1 +/-mast cell conditioned media with TGF-ß blocking antibody. These data supported the growing idea that the Nf1 +/-mast cell is the critical effector in the For personal use only. on July 9, 2017. by guest www.bloodjournal.org From paracrine induction of neurofibroma pathogenesis. Interestingly, TGF-ß dependent
Nf1
+/-fibroblast hyperactivity appears to result from increased kinase activity of c-abl secondary to increased Ras-GTP. Accordingly, imatinib mesylate (Gleevec©) inhibits both in vitro collagen production and in vivo fibroblast migration in the dermal tissue of mice given subcutaneous TGF-ß or Nf1 +/-mast cell conditioned media. (Figure 4 ). Following three months of treatment, magnetic resonance imaging revealed a remarkable 70% reduction in tumor volume, and the complications associated with the airway compression had resolved. After the tumor ceased its regression and appeared stable, treatment was terminated. 5 The patient remains stable and in relatively good health ( Figure 6 ). Encouraged by the mouse model and the successful medical treatment of this index patient, a phase II clinical trial involving NF1 patients suffering from highly morbid neurofibromas has been initiated.
An SCF/c-Kit signaling axis in the
For
Other cell lineages and future directions
While we have principally discussed interactions among Schwann cells and the hematopoietic microenvironment in the context of neurofibroma formation, other lineages in the microenvironment are clearly involved in tumor progression and are potential targets for drug treatment. Neo-angiogenesis is required for tumor expansion and metastasis in multiple human cancers, 54, 79 and previous data indicated that Nf1 For personal use only. on July 9, 2017. by guest www.bloodjournal.org From growth factors (e.g. NGF, VEGF, PDGF, bFGF, and TGF-ß). These secreted factorsalong with factors secreted by the Schwann cell -stimulate fibroblasts, endothelial cells (ECs), and smooth muscle cells, promoting extracellular matrix remodeling, collagen deposition, chemotaxis, neo-angiogenesis, and generalized inflammation. 5, 20, 36, 46, 57, 67, 68, 72, 75 (also, unpublished). Whether a subset of these secreted molecules has a particularly seminal role in the initiation of tumorigenesis is an area of experimentation that may provide both more specific therapies and potentially inform other neoplastic conditions potentiated by inflammatory microenvironments. 52, 53, 55 Importantly, a deeper understanding of the cellular and biochemical mechanisms inducing tumor regression during imatinib treatment would directly inform -and perhaps improve -the medical management of human patients with established plexiform neurofibromas. Finally, while mast cell inflammation underpins the murine plexiform neurofibroma microenvironment and undoubtedly contributes to the human condition, we have not explored cellular events required for the transition to the malignant peripheral nerve sheath tumor. The continuing refinement of murine models, the use of mouse genetics, and advances in vivo experimental imaging are important tools that may help provide additional insights into these processes.
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